|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Baxter International Inc manufactures medical products across seven major reported business segments. The renal segment (33% of sales) includes hemodialysis and peritoneal dialysis products, while acute therapies (5% of sales) also focuses on near-term kidney issues for patients. Medication delivery (25% of sales) includes IV pumps and solutions. Pharmaceuticals (18% of sales) consists primarily of injectable drugs, anesthetic gases, and compounding services. Nutrition (8% of sales) includes parenteral nutrition therapies. Advanced surgery (7% of sales) mostly incorporates hemostasis products and biosurgical sealants. Contract manufacturing services round out the roughly remaining 4% of sales.
BAX $78.80 +1.18 (1.51%)
Sector Health Care
Industry Medical Equipment & Devices
Market Cap 39.79 Billion
EPS 0.66 P/E Ratio 25.83
Previous Earnings Wed, Oct 31, 2018
Latest Earnings Thu, Jan 31, 2019
Dividend 0.96% / $0.76
Ex-Date Thu, Feb 28, 2019
Dividend Pay Date Mon, Apr 1, 2019
Dividend History 113 Payments (Quarterly)
Investing Quotes #Legendary
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.